Mode
Text Size
Log in / Sign up

Chronic Kidney Disease Stage 5

Part of Kidney Diseases

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Chronic Kidney Disease Stage 5

6 trials tracked for Chronic Kidney Disease Stage 5: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 3 citations.

6Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 2 Other / NA 1
  1. Phase 4 Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5 Completed · 3 cited
  2. Phase 4 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease Completed
  3. Phase 3 Head to Head Study Against Sevelamer Hydrochloride Completed
  4. Phase 2 Blood Pressure Lowering in Dialysis (BOLD) Trial Completed
  5. Phase 2 Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis Completed
  6. N/A Quality of Life and Depression in Dialysis Patients Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Chronic Kidney Disease Stage 5: what the trials found

Clinical investigations into mineral management in CKD Stage 5 include the use of Fosrenol (Lanthanum Carbonate). In a Phase 3 trial, administration of Fosrenol resulted in statistically significant changes in serum calcium levels at 4 weeks (p=0.0249) 3. However, the change from baseline in serum phosphorus levels at 4 weeks did not reach statistical significance (p=0.1130) 3.

Evaluations of Zemplar® injection for mineral management showed no statistically significant difference in calcium absorption fractions when analyzed by ANOVA (p=0.573) or Mixed Model (p=0.670) 2. Telavancin has also been evaluated in a Phase 4 study for this population 1.

Recent results — preliminary, needs further review

  • AZD1722 showed a statistically significant reduction in stool sodium content (p=<0.0001), though it did not significantly impact mean weekly interdialytic weight gain (p=0.46) 5.
  • A study of peritoneal dialysis patients found a statistically significant association between hydration status and scores for depression and quality of life (p=0.008) 6.
  • Data regarding the duration of recovery from dialysis treatments following anti-hypertensive medication use is currently unconfirmed 4.

For the clinician treating this condition

  • Fosrenol (Lanthanum Carbonate) is associated with significant changes in serum calcium levels at 4 weeks, but its impact on serum phosphorus levels was not statistically confirmed 3.
  • Zemplar® injection did not demonstrate a statistically significant effect on calcium absorption fractions in clinical testing 2.

AI synthesis of 6 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Kidney Diseases

Related studies from across the Kidney Diseases family.

Insulin resistance and hyperinsulinemia drive bidirectional links between biological aging and age-related chronic diseases
Diabetes & Endocrinology Sys. Review
Insulin resistance and hyperinsulinemia drive bidirectional links between biological aging and age-related chronic diseases Insulin Resistance Links Aging and Chronic Diseases
This narrative review explores the reciprocal relationship between insulin resistance, hyperinsulinemia, and mechanisms of biological aging.…
This review explores how insulin resistance and high insulin levels connect aging to diseases like diabetes, heart disease, and kidney disea…
Frailty associated with higher odds of cognitive impairment in patients with chronic kidney disease
Nephrology Meta-analysis
Frailty associated with higher odds of cognitive impairment in patients with chronic kidney disease Frailty increases risk of cognitive issues in kidney disease patients
This meta-analysis of 129,868 patients with chronic kidney disease (CKD) found that frailty is associated with a significantly higher risk o…
People with chronic kidney disease who experience frailty are much more likely to face memory and thinking problems than those who stay robu…
Chronic kidney disease prevalence of 13.7% identified across 19 African countries
Nephrology Meta-analysis
Chronic kidney disease prevalence of 13.7% identified across 19 African countries New data shows high rates of kidney disease across Africa
This systematic review and meta-analysis of 91,723 adults in Africa found a pooled CKD prevalence of 13.7% for stages 1 to 5. The study also…
A large-scale review reveals that over 13% of adults in many African countries live with chronic kidney disease.
GLP-1 receptor agonists and tirzepatide provide cardiovascular benefits across multiple clinical scenarios
Diabetes & Endocrinology Sys. Review
GLP-1 receptor agonists and tirzepatide provide cardiovascular benefits across multiple clinical scenarios Incretin Drugs Show Heart Benefits Across Multiple Conditions
This state-of-the-art review synthesizes evidence regarding incretin analogues, specifically GLP-1 receptor agonists and tirzepatide. The re…
GLP-1 drugs and tirzepatide prove heart benefits in diabetes, obesity, heart failure, and more.
Natural products offer multi-target renoprotective effects for metabolic, inflammatory, and oxidative stress pathways
Nephrology Sys. Review
Natural products offer multi-target renoprotective effects for metabolic, inflammatory, and oxidative stress pathways Natural compounds show promise for kidney disease
This systematic review examines the role of natural products including polysaccharides, flavonoids, and phenolic acids in managing diabetic …
Natural compounds from plants may help protect kidneys by targeting multiple disease pathways at once.
Inflammation and immune dysregulation drive chronic kidney disease progression and associated tissue remodeling
Nephrology Sys. Review
Inflammation and immune dysregulation drive chronic kidney disease progression and associated tissue remodeling Inflammation and Immune Issues Drive Chronic Kidney Disease Progression
This mini review synthesizes the role of inflammation and immune dysregulation in the initiation and progression of chronic kidney disease. …
Persistent inflammation and immune system issues are central drivers of chronic kidney disease, leading to tissue damage and potential compl…
Herbal Medicinal Bath shows stable efficacy for chronic kidney disease-associated pruritus in network meta-analysis
Anesthesiology & Pain Medicine Meta-analysis
Herbal Medicinal Bath shows stable efficacy for chronic kidney disease-associated pruritus in network meta-analysis Herbal medicinal baths may relieve itching in kidney disease
This systematic review and network meta-analysis of 1,968 patients evaluated 12 complementary therapies for chronic kidney disease-associate…
New research suggests herbal medicinal baths are a reliable way to soothe persistent itching for people with chronic kidney disease.
Finerenone Efficacy and Safety in Patients with Chronic Kidney Disease and Glomerular Disease
Nephrology RCT
Finerenone Efficacy and Safety in Patients with Chronic Kidney Disease and Glomerular Disease Finerenone slows kidney function loss in patients with glomerular disease
Finerenone significantly slows eGFR decline and reduces albuminuria in patients with glomerular disease, offering a new therapeutic option f…
A new clinical trial shows that the medication finerenone helps slow kidney decline and reduces protein in the urine for people with specifi…
Vitamin D supplementation shows low certainty reductions in urinary markers for diabetic kidney disease
Nephrology Meta-analysis
Vitamin D supplementation shows low certainty reductions in urinary markers for diabetic kidney disease Vitamin D shows limited benefit for diabetic kidney disease
This umbrella review meta-analysis evaluates vitamin D and its analogs in patients with diabetic kidney disease. While some reduction in uri…
Vitamin D may lower protein in urine for diabetic kidney disease, but evidence is weak and no benefit for kidney function or survival.
Unified cardiometabolic disease framework links T2DM, ASCVD, HFpEF, MASLD, hypertension, and CKD via shared pathophysiology
Cardiology Guideline
Unified cardiometabolic disease framework links T2DM, ASCVD, HFpEF, MASLD, hypertension, and CKD via shared pathophysiology New Framework Links Heart and Kidney Health in Diabetes
This guideline provides a narrative review of the unified cardiometabolic disease (UCD) continuum. It argues that conditions like T2DM, ASCV…
Experts suggest that diabetes, heart failure, and kidney disease may share a single underlying cause rather than being separate conditions.
Age, male sex, low BMI, and comorbidities like diabetes are significant risk factors for sepsis incidence
Diabetes & Endocrinology Meta-analysis
Age, male sex, low BMI, and comorbidities like diabetes are significant risk factors for sepsis incidence Age, diabetes, and COPD raise sepsis risk, meta-analysis finds
This meta-analysis of 21 studies identifies several significant risk factors associated with increased sepsis incidence, including age over …
A new analysis of 21 studies pinpoints key risk factors for sepsis, including age, diabetes, and COPD.
m6A modification regulates renal tubular epithelial cell fate and inflammatory responses in acute kidney injury
Allergy & Immunology Sys. Review
m6A modification regulates renal tubular epithelial cell fate and inflammatory responses in acute kidney injury Gene modification may drive kidney injury, review finds
This systematic review examines the role of N6-methyladenosine (m6A) modification in the progression of acute kidney injury. The authors con…
A new review reveals that a chemical modification to RNA, called m6A, plays a key role in acute kidney injury by affecting cell death and in…